EMAIL THIS PAGE TO A FRIEND

Breast cancer (Tokyo, Japan)

Preoperative endocrine therapy with goserelin acetate and tamoxifen in hormone receptor-positive premenopausal breast cancer patients.


PMID 23184499

Abstract

The use of preoperative endocrine therapy for breast cancer has increased during the last decade. Although several studies have reported favorable response rates in postmenopausal women, its effectiveness in premenopausal women remains unknown. This study therefore aimed to evaluate the potential benefits of preoperative endocrine therapy in premenopausal women. Fifty-three patients with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative invasive breast cancer were included in this study. Preoperative endocrine therapy with goserelin acetate and tamoxifen was administered for 3 months. Clinical evaluations were performed by ultrasonography before and after endocrine therapy. Pathological evaluations were performed using core biopsy and surgical specimens. Immunohistochemical evaluations of ER, progesterone receptor (PgR), HER2, and Ki-67 were performed before and after endocrine therapy. Partial response (PR) was observed in 23 % (12/53) and progressive disease (PD) in 2 % (2/53) of patients. Significant suppression of Ki-67 was observed following endocrine therapy in 90 % (47/52) of patients (P < 0.0001). Significant downregulation of PgR was observed after endocrine therapy (P = 0.0002), which tended to be correlated with clinical response (P = 0.058). Three months of preoperative endocrine therapy with goserelin acetate and tamoxifen was safe and effective in premenopausal patients with invasive breast cancer, with a 23 % PR rate. Changes in PgR and Ki-67 expression might be promising markers for endocrine responsiveness.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB4300350
Anti-ERBB2 (Ab-1221/1222) antibody produced in rabbit, affinity isolated antibody
SAB4300351
Anti-ERBB2 (Ab-1248) antibody produced in rabbit, affinity isolated antibody
SAB4300349
Anti-ERBB2 (Ab-877) antibody produced in rabbit, affinity isolated antibody
SAB1408982
Anti-EREG antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
SAB4300344
Anti-ESR1 (Ab-104) antibody produced in rabbit, affinity isolated antibody
SAB4300345
Anti-ESR1 (Ab-106) antibody produced in rabbit, affinity isolated antibody
SAB4300346
Anti-ESR1 (Ab-118) antibody produced in rabbit, affinity isolated antibody
SAB4300347
Anti-ESR1 (Ab-167) antibody produced in rabbit, affinity isolated antibody
SAB2100711
Anti-ESR1 (ab1) antibody produced in rabbit, affinity isolated antibody
SAB2100712
Anti-ESR1 (ab2) antibody produced in rabbit, affinity isolated antibody
GW21182 Anti-ESR1 antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
HPA000449
Anti-ESR1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
HPA000450
Anti-ESR1 antibody produced in rabbit, Ab2, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB2104971
Anti-ESR1, (N-terminal) antibody produced in rabbit, affinity isolated antibody
E0521 Anti-Estrogen Receptor (18-32) antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
HPA001383
Anti-HER2 antibody produced in rabbit, Ab1, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB4500782
Anti-HER2 antibody produced in rabbit, affinity isolated antibody
SAB4500783
Anti-HER2 antibody produced in rabbit, affinity isolated antibody
SAB4500787
Anti-HER2 antibody produced in rabbit, affinity isolated antibody
SAB4500789
Anti-HER2 antibody produced in rabbit, affinity isolated antibody
SAB1401128
Monoclonal Anti-EREG antibody produced in mouse, clone 1E6, purified immunoglobulin, buffered aqueous solution
AMAB90867
Monoclonal Anti-ESR1 antibody produced in mouse, Prestige Antibodies® Powered by Atlas Antibodies, clone CL1196, purified immunoglobulin, buffered aqueous glycerol solution
SAB1402766
Monoclonal Anti-ESR1 antibody produced in mouse, clone 2F8, purified immunoglobulin, buffered aqueous solution
SAB5300303
Monoclonal Anti-ESR1 antibody produced in mouse, clone 2B7, purified immunoglobulin, buffered aqueous solution
SAB5300304
Monoclonal Anti-ESR1 antibody produced in mouse, clone 5D4B1, ascites fluid
SAB5300305
Monoclonal Anti-ESR1 antibody produced in mouse, clone 10H12B10, ascites fluid
SAB5300306 Monoclonal Anti-ESR1 antibody produced in mouse, clone 8H9A10, ascites fluid
SAB5300307 Monoclonal Anti-ESR1 antibody produced in mouse, clone 2G112B3, ascites fluid
SAB5300308
Monoclonal Anti-ESR1 antibody produced in mouse, clone 6B6, ascites fluid